135 Citazioni (Scopus)


The high incidence of multidrug-resistant (MDR) bacteria among patients admitted to ICUs has determined an increase of tigecycline (TGC) use for the treatment of severe infections. Many concerns have been raised about the efficacy of this molecule and increased dosages have been proposed. Our purpose is to investigate TGC safety and efficacy at higher than standard doses.
Lingua originaleEnglish
pagine (da-a)R90-R90
Numero di pagine9
RivistaCritical Care
Stato di pubblicazionePubblicato - 2014


  • tygecicline

Fingerprint Entra nei temi di ricerca di 'High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria'. Insieme formano una fingerprint unica.

Cita questo